(600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 600535 · · 11 pages · Chinese
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Tasly Pharmaceutical
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Obtaining Drug Registration Certificate by Subsidiary
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Obtaining the Drug Clinical Trial Approval Notice
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Election of Employee Director
- (600535)"TASLY PHARMACEUTICAL GROUP CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical